At a Glance
| 4-AcO-MiPT | ETH-LAD | |
|---|---|---|
| Class | Psychedelic | Psychedelic |
| Common Dose (oral) | 15–20 mg | 60–150 µg |
| Total Duration | 2.8–6 hrs | 5.1–8.2 hrs |
| Routes | oral | oral |
| Effects | 58 documented | 81 documented |
4-AcO-MiPT, a Psychedelic, and ETH-LAD, a Psychedelic, are frequently compared by users looking to understand their relative effects, dosage profiles, and safety considerations. Both are classified as Psychedelics, meaning they share a common pharmacological foundation. They share 50 documented effects in common, with 8 effects unique to 4-AcO-MiPT and 31 unique to ETH-LAD. This side-by-side comparison covers dosage, duration, subjective effects, and safety to help you make informed decisions.
| 4-AcO-MiPT | ETH-LAD | |
|---|---|---|
| Class | Psychedelic | Psychedelic |
| Common Dose (oral) | 15–20 mg | 60–150 µg |
| Total Duration | 2.8–6 hrs | 5.1–8.2 hrs |
| Routes | oral | oral |
| Effects | 58 documented | 81 documented |
| Level | 4-AcO-MiPT | ETH-LAD |
|---|---|---|
| Threshold | 5 mg | 15 µg |
| Light | 10–15 mg | 30–60 µg |
| Common | 15–20 mg | 60–150 µg |
| Strong | 20–35 mg | 150–225 µg |
| Heavy | 35 mg | 225 µg |
4-AcO-MiPT
ETH-LAD
No direct interaction data available between these substances. This does not mean the combination is safe.
No dangerous interactions recorded.
No dangerous interactions recorded.